As injectable pipelines grow more complex, fill‑finish has become one of the most critical and capacity‑constrained steps in pharmaceutical manufacturing. From sterile filling and lyophilization to packaging and quality systems, performance at this stage directly impacts timelines, compliance, and product integrity.
In these sessions, CDMOs present their current capabilities, including technologies, facility footprints, and real‑time capacity, through short, focused digital briefings. This format gives viewers a clear, practical look at available fill-finish options to assess fit for development or commercial needs.
Designed for biopharma teams actively evaluating manufacturing partners, along with consultants, investors, and participating CDMOs looking to connect around real opportunities — not hypotheticals. The goal is simple: make it easier to find the right partner, faster.
Recent Sessions Available On-Demand
Small Molecule Drug Substance/Small Molecule Drug Product – 3/11/2026
Cell & Gene Therapy/Analytical Service – 3/12/2026
Large Molecule Manufacturing/Fill-Finish – 3/10/2026
Upcoming OPCU Topics & Times
Mammalian Cell Culture | 5/19/2026, AM Session
Highly Potent Drug Development & Manufacturing | 5/19/2026, PM Session
Combination Products & Drug Delivery | 5/20/2026, AM Session
Large Molecule | 5/20/2026, PM Session
Access more on-demand OPCU recordings and upcoming sessions here.
